Norman Ng: New Hope for Terminal Patients
Norman Ng, Director, Patient Advocacy and Public Affairs at Healthcare Thinkers, shared on LinkedIn:
“China’s Innovative Drug Boom: New Hope for Terminal Patients
In recent years, China’s biopharmaceutical industry has been rising at an unprecedented pace—not just catching up in technology, but leading in innovation. This magazine cover features a red-and-white capsule as its visual centerpiece, symbolizing breakthrough efficacy and an explosive release of hope. Chinese innovative drugs are reshaping the global healthcare landscape.
Targeting critical illnesses like cancer and heart disease, Chinese pharmaceutical companies are no longer mere imitators—they are pioneers. Their newly developed drugs are filling clinical gaps and offering a lifeline to countless patients.
The companies featured on the cover – Hengrui, BeOne, RemeGen, 3SBio, Akeso, and Hutchmed – are the key players in this medical revolution. Their R&D pipelines span cutting-edge technologies such as immunotherapy, targeted treatments, and antibody drugs, steadily breaking through technical barriers and stepping onto the global stage.
It is a beacon of hope for patients worldwide. When innovation knows no borders, hope is no longer out of reach.”
More posts featuring Norman Ng.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023